Aging impairs innate immune response to flu

December 13, 2017 by Ziba Kashef, Yale University
Credit: stock.adobe.com

Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death from flu, the researchers said.  

The study is published in Science Signaling.

"Influenza virus mortality is the highest in . This study sheds light on a mechanism that underlies this impaired antiviral response," said senior author Akiko Iwasaki, the Waldemar Von Zedtwitz Professor of Immunobiology and Howard Hughes Medical Institute investigator at Yale School of Medicine.

Iwasaki and her colleagues investigated the innate, or inborn, to the flu virus. The Yale team collected blood samples from healthy young adults and older adults aged 65 and above. They isolated monocytes, a type of white blood cell, from the samples and stimulated the monocytes with either flu virus or a mimic of the virus.

The immune response in cells from older adults was severely impaired in critical ways, the researchers found. To fight the , the body needs to activate potent antiviral proteins called interferons. But in older adults, this response is weakened by age-related damage to a molecule, TRAF3, that signals immune cells to make interferon. Without that signal, and another involving antiviral genes, resistance to flu falls short, they noted.

The finding offers new insight into why flu disease is severe in older adults, said Iwasaki, and points to a potential strategy for reducing flu-related mortality in that age group.

"In older adults, we might have to use a different strategy to treat and immunize against flu," she said. "We need to find a way to boost antiviral defense that does not rely on interferon production. For vaccines, we need to find an adjuvant—a component added to a vaccine—that would still stimulate the in older adults."

Explore further: Study suggests immune response to flu causes death in older people, not the virus

More information: Ryan D. Molony et al. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes, Science Signaling (2017). DOI: 10.1126/scisignal.aan2392

Related Stories

Study suggests immune response to flu causes death in older people, not the virus

April 21, 2016
A new Yale-led study suggests that death from influenza virus in older people may be primarily caused by a damaging immune response to flu and not by the virus itself. The insight could lead to novel strategies for combating ...

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

New knowledge on how HIV beats the body's early immune response

September 14, 2017
In an important step towards eradicating HIV-associated viral reservoirs, researchers at Sydney's Westmead Institute for Medical Research have identified how the HIV virus hijacks the innate immune system to facilitate its ...

Warmer body temperature puts the heat on the common cold

July 11, 2016
A new Yale study reveals how body temperature affects the immune system's response to the common cold virus. The research, published by the Proceedings of the National Academy of Sciences, may provide additional strategies ...

Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease, study finds

October 23, 2017
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a vaccine for respiratory syncytial ...

Cold virus replicates better at cooler temperatures

January 5, 2015
The common cold virus can reproduce itself more efficiently in the cooler temperatures found inside the nose than at core body temperature, according to a new Yale-led study. This finding may confirm the popular yet contested ...

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.